As resveratrol degraded DDX5 protein and the depletion of DDX5 inhibited the mTORC1 pathway and growth of prostate cancer cells, we evaluated the significance of degrading DDX5 in the anticancer effects of resveratrol. The gene discussed is DDX5; the disease is prostate cancer.